Chronic obstructive pulmonary disease: Consequences beyond the lung

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 12, Issue 1, 2012, Pages 71-74

  Shrikrishna, Dinesh ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COR PULMONALE; DISEASE ASSOCIATION; FORWARD HEART FAILURE; GASTROESOPHAGEAL REFLUX; HEART INFARCTION; HUMAN; MUSCLE ATROPHY; MUSCLE CRAMP; MUSCLE WEAKNESS; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; QUADRICEPS FEMORIS MUSCLE; REVIEW; SKELETAL MUSCLE WEAKNESS; STROKE;

EID: 84859359076     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.12-1-71     Document Type: Review

References (32)

1. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. (Pubitemid 38807371)
2. Agusti A, Calverley PM, Celli B et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
4. Swallow EB, Reyes D, Hopkinson NS et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-20.
5. Dodd JW, Hogg L, Nolan J et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011;66:425-9.
6. Seymour JM, Spruit MA, Hopkinson NS et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8.
7. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458-63. (Pubitemid 46354249)
8. Hopkinson NS, Polkey MI. Does physical inactivity cause chronic obstructive pulmonary disease? Clin Sci (Lond) 2010;118:565-72.
9. Swallow EB, Gosker HR, Ward KA et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 2007;103:739-46. (Pubitemid 47358853)
10. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;(4):CD003793.
11. Shrikrishna D, Hopkinson NS. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Med COPD Update 2009;5:7-13.
12. Spruit MA, Gosselink R, Troosters T et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003;58:752-6. (Pubitemid 37094049)
13. Hopkinson NS, Tennant RC, Dayer MJ et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007;8:25.
14. Seymour JM, Moore L, Jolley CJ et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010;65:423-8.
15. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004;329:1209.
16. Puhan MA, Gimeno-Santos E, Scharplatz M et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;(10):CD005305.
17. Similowski T, Yan S, Gauthier AP, Mackle PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991;325:917-23.
18. Iwamoto H, Yokoyama A, Kitahara Y et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009;179:35-40
19. Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S.Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001;164:597-601 (Pubitemid 32801663)
20. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80 (Pubitemid 38901515)
21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9 (Pubitemid 27152782)
22. Barr RG, Bluemke DA, Ahmed FS et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217-27
23. Feary JR, Rodrigues LC, Smith CJ, Hubbards RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010;65:956-62
24. Høiseth AD, Neukamm A, Karlsson BD et al. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 2011;66:775-81.
25. Stark-Leyva KN, Beck KC, Johnson BD. Influence of expiratory loading and hyperinflation on cardiac output during exercise. J Appl Physiol 2004;96:1920-7. (Pubitemid 38580021)
26. Ferguson GT, Calverley PM, Anderson JA et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health Study. Chest 2009;136:1456-65.
27. Janssens W, Bouillon R, Claes B et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215-20.
28. Hopkinson NS, Sharshar T, Ross ET et al. Corticospinal control of respiratory muscles in chronic obstructive pulmonary disease. Respir Physiol Neurobiol 2004;141:1-12 (Pubitemid 38953748)
29. Jann S, Gatti A, Crespi S, Rolo, J, Biretta S. Peripheral neuropathy in chronic respiratory insufficiency. J Peripher Nerv Syst 1998;3:69-74. (Pubitemid 28137398)
30. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35:913-22.
31. Hurst JR, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
32. Boutou AK, Stanopoulos I, Pitsiou GG et al. Anaemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011;82:237-45.